News/ Top stories AbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoon Richard Staines AbbVie, Harpoon, R&D 0 Comment AbbVie has signed a deal worth up to $2.4 billion with the US biotech Harpoon Therapeutics, expanding a Share X AbbVie signs potential $2.4bn cancer immunotherapy deal with Harpoon https://pharmaphorum.com/news/abbvie-signs-potential-2-4bn/
